In line with these studies, the absolute numbers of HER2+EVs that we detected in the plasma of breast cancer patients with the optimised flow cytometric analysis also did not correlate with tumour size, tumour stage, or metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.